KEZAR LIFE SCIENCES INC

$5.49 0.00% ($0.00)

Get ready to invest

About KEZAR LIFE SCIENCES INC

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer. The Company is developing small-molecule therapies that harness master regulators of cellular function to inhibit multiple drivers of disease via single. The Company's product portfolio includes KZR-616 and KZR-261. The KZR-616 is a selective immunoproteasome inhibitor being evaluated in Phase II clinical trials in lupus nephritis, dermatomyositis, and polymyositis. In addition, KZR-261 is an anti-cancer clinical candidate targeting the Sec61 translocon and the protein secretion pathway. The Company is focusing its initial development of KZR-616 in severe, chronic and orphan immune-mediated diseases. The Company’s principal operations are in South San Francisco, California.

Popular Stocks	Price	Change
Nu Holdings NU	$4.33 13.35%	13.35%
Annaly NLY	$6.27 1.42%	1.42%
AMD AMD	$96.67 0.41%	0.41%
Nvidia NVDA	$171.24 1.1%	1.1%
SoFi Technologies, Inc. SOFI	$7.75 7.19%	7.19%
Ford F	$12.85 0.55%	0.55%
Apple AAPL	$137.35 2.46%	2.46%
Cisco CSCO	$41.72 13.73%	13.73%
Grab Holdings inc. GRAB	$3.14 24.11%	24.11%
NIO NIO	$16.66 5.24%	5.24%